StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)

Close on Nov 17, 2026Market cap $364.00MP/E –Yield –

CorMedix price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

CorMedix's price to sales ratio was 0.9× on Nov 11, 2026, against 3.6× a year earlier. Over the last 3 years it ranged from 0.9× to 478.8×, with a median of 10.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×−3.4
2025Dec 31, 20254.3×−371.8
2020Apr 30, 2020376.0×+153.7
2019Oct 31, 2019222.3×−91.3
2018Jun 29, 2018313.6×–

More CorMedix figures

See a number that looks wrong?